Recent evidence showed that promoter hypomethylation increases ITPR3 expression while promoter hypermethylation reduce OGDHL expression in HCC [10, 11], which indicates that epigenetic regulation plays an important role in HCC development and there are promising epigenetic therapy targets for HCC patients. Here, OGDHL is linked to hepatocellular carcinoma.